The characteristic feature of glucocorticoids after local application with reference to leucocyte migration and protein exudation.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001623:Betamethasone / Q000494:pharmacology; D002463:Cell Membrane Permeability / Q000187:drug effects; D005122:Exudates and Transudates / Q000187:drug effects*; D005446:Fluocinolone Acetonide / Q000494:pharmacology; D005938:Glucocorticoids / Q000494:pharmacology*; D006854:Hydrocortisone / Q000494:pharmacology; D007249:Inflammation / Q000139:chemically induced / Q000503:physiopathology; D007962:Leukocytes / Q000187:drug effects* / Q000503:physiopathology; D008297:Male; D008747:Methylcellulose; D011239:Prednisolone / Q000494:pharmacology; D051381:Rats; D014222:Triamcinolone Acetonide / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D005446:Fluocinolone Acetonide; D008747:Methylcellulose; D001623:Betamethasone; D011239:Prednisolone; D014222:Triamcinolone Acetonide; D006854:Hydrocortisone